drugset / Trial / NCT06685120

Combined Use of PRP and Hyaluronic Acid for Infiltrative Treatment of Patients With Knee Osteoarthritis

NCT06685120 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

"PRP+HA-23" is a double-blind randomized controlled clinical trial with 1:1:1 allocation. The objective of the study is to evaluate by a randomized controlled, double-blind clinical trial the efficacy and safety of viscosupplementation-associated PRP infiltration compared with PRP-only or HA-only infiltration for the treatment of patients with knee osteoarthritis.

Timeline

Start
2025-12-11
Primary completion
2029-09
Completion
2029-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject HA Unknown 40 mg Other
Subject PRP Unknown 5 ml Other

Indications